Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114890912B reveals efficient nickel-catalyzed synthesis of fluorinated intermediates, offering cost reduction and scalable supply chain solutions for pharma.
Patent CN109134362B details a metal-free photocatalytic method for nitrogen heterocycles, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Novel asymmetric synthesis patent CN106496099B offers high purity lobeline intermediate with cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN106349150B reveals efficient Pd-catalyzed carbonylation. Enables cost reduction in API intermediate manufacturing with high purity and scalable processes for global supply chains.
Patent CN111170918A details a cost-effective iridium-catalyzed C-H amination route for lactams, offering significant supply chain stability and reduced manufacturing costs for pharma intermediates.
Patent CN1295209C details a green selenium-catalyzed reduction of azo compounds using CO. This method offers high purity pharmaceutical intermediates with significant cost and safety advantages.
Improved sildenafil synthesis patent CN106117212B offers high purity and cost reduction in API manufacturing for global supply chains.
Patent CN112739683B reveals a novel Brivaracetam synthesis using Quinine catalysts. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Rh-catalyzed method for 1,3-benzodiazepines with anticancer activity. Efficient route for pharmaceutical intermediates offering cost reduction.
Novel green synthesis of beta-cyano ketones using acetone cyanohydrin. High yield, low toxicity, scalable process for pharmaceutical intermediates.
Patent CN114075108A details a metal-free visible light method for aldehyde deuteration, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel one-step synthesis reduces cost and steps for high-purity pharmaceutical intermediates supply chain optimization and commercial scale production.
Patent CN114181132A reveals a novel high-purity synthesis route for nintedanib intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel condensation route for Anserine intermediate CN112624977A offers high purity and scalable manufacturing for food and pharma applications.
Patent CN103896816A reveals advanced Ir-catalyzed synthesis for chiral allyl thiocarboxylates. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN102781948A details stable P-chiral aminodiphosphine ligands enabling high-ee asymmetric hydrogenation for cost-effective chiral pharmaceutical intermediates manufacturing.
Patent CN111574487B details a novel asymmetric hydrogenation method for producing high-purity chiral dihydroisoflavones, offering significant supply chain and cost advantages.
Patent CN105111217A details copper-catalyzed one-pot synthesis offering high purity and efficient supply chain solutions for global pharmaceutical intermediate manufacturing partners.
Novel beta-site nucleophilic substitution method disclosed in patent. High selectivity, mild conditions. Reliable supply chain for fluorine intermediates manufacturing.
Patent CN104193628A reveals a novel one-step synthesis for amino aryl ketones. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.